New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be ...

Czechia proposes changes that will better define the role of patient organisations when informing patients about therapeutic procedures without violating advertising regulations.

Jarubas tells Euractiv there's a delicate threshold to be found between a purely commercial approach and ensuring strategic security.